Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate

Overview of attention for article published in Biomedicines, May 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#7 of 4,379)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 43 news stories from 43 outlets.

TEL AVIV, Israel, June 12, 2023 /PRNewswire/ -- Tarsier Pharma Ltd., a late clinical stage pharmaceutical company focused on…

TEL AVIV, Israel, June 12, 2023 /PRNewswire/ -- Tarsier Pharma Ltd., a late clinical stage pharmaceutical company focused on…

TEL AVIV, Israel, June 12, 2023 /PRNewswire/ -- Tarsier Pharma Ltd., a late clinical stage pharmaceutical company focused on…

TEL AVIV, Israel, June 12, 2023 /PRNewswire/ -- Tarsier Pharma Ltd., a late clinical stage pharmaceutical company focused on…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 39 additional news stories.